Hiromi Omura

Tottori, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

TP53-mutated Therapy-related Leukemia with the Der(5;17)(p10;q10) Chromosomal Abnormality Following Chemotherapy for Acute Promyelocytic Leukemia Bridged to Allogeneic Hematopoietic Stem Cell Transplantation Using CPX-351.

TP53-mutated Therapy-related Leukemia with the Der(5;17)(p10;q10) Chromosomal Abnormality Following Chemotherapy for Acute Promyelocytic Leukemia Bridged to Allogeneic Hematopoietic Stem Cell Transplantation Using CPX-351.

Journal: Internal medicine (Tokyo, Japan)

Published: August 10, 2026

Effectiveness and tolerability of switching from 20% subcutaneous immunoglobulin to hyaluronidase-facilitated subcutaneous immunoglobulin 10% in the same patients with secondary hypogammaglobulinemia.

Effectiveness and tolerability of switching from 20% subcutaneous immunoglobulin to hyaluronidase-facilitated subcutaneous immunoglobulin 10% in the same patients with secondary hypogammaglobulinemia.

Journal: International journal of hematology

Published: February 27, 2026

Real-world evidence from Japan in patients with hematological malignancies and secondary hypogammaglobulinemia treated with 20% subcutaneous immunoglobulin, Ig20Gly: A retrospective cohort study.

Real-world evidence from Japan in patients with hematological malignancies and secondary hypogammaglobulinemia treated with 20% subcutaneous immunoglobulin, Ig20Gly: A retrospective cohort study.

Journal: Medicine

Published: June 15, 2025

Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan.

Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan.

Journal: Hematology (Amsterdam, Netherlands)

Published: April 16, 2024

Presence and Onset of Chronic Kidney Disease as a Factor Involved in the Poor Prognosis of Patients with Essential Thrombocythemia.

Presence and Onset of Chronic Kidney Disease as a Factor Involved in the Poor Prognosis of Patients with Essential Thrombocythemia.

Journal: Advances in hematology

Published: November 15, 2023

Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.

Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.

Journal: International journal of hematology

Published: January 28, 2023

Mucosa-associated lymphoid tissue lymphoma of the bladder: Case report.

Mucosa-associated lymphoid tissue lymphoma of the bladder: Case report.

Journal: Urology case reports

Published: February 13, 2021

Marked Rebound of Platelet Count in the Early Postpartum Period in a Patient with Essential Thrombocythemia.

Marked Rebound of Platelet Count in the Early Postpartum Period in a Patient with Essential Thrombocythemia.

Journal: Case reports in hematology

Published: December 28, 2020

Causes of catheter removal and complications depending on the insertion side of peripherally inserted central venous catheter in patients with hematologic disorders

Causes of catheter removal and complications depending on the insertion side of peripherally inserted central venous catheter in patients with hematologic disorders

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: December 10, 2020

Catheter-related bloodstream infection associated with multiple insertions of the peripherally inserted central catheter in patients with hematological disorders.

Catheter-related bloodstream infection associated with multiple insertions of the peripherally inserted central catheter in patients with hematological disorders.

Journal: Scientific reports

Published: August 13, 2020

Comparison of starting doses of anagrelide as a first-line therapy in patients with cytoreductive therapy-naïve essential thrombocythemia: difference between starting at 0.5 and 1.0 mg/day.

Comparison of starting doses of anagrelide as a first-line therapy in patients with cytoreductive therapy-naïve essential thrombocythemia: difference between starting at 0.5 and 1.0 mg/day.

Journal: International journal of hematology

Published: January 14, 2020

Successful Management of Primary Mediastinal Large B-cell Lymphoma during Pregnancy.

Successful Management of Primary Mediastinal Large B-cell Lymphoma during Pregnancy.

Journal: Internal medicine (Tokyo, Japan)

Published: August 09, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026